Conspectus
The concept of umpolung, or polarity reversal,
introduced by Seebach
and Corey nearly half a century ago, ushered a new paradigm into synthetic
chemistry. Novel connections were able to be forged among functional
groups that were typically inaccessible. Conceptually, an umpolung
reaction is identified only upon retrosynthetic analysis. Stoichiometric
examples have served as a platform to develop and refine elegant methodologies
into catalytic processes. The advent of these unconventional arrangements
of canonical synthons into new points of diversity has expanded the
repertoire of the synthetic toolbox. Within this context, asymmetric
organocatalyzed methodologies remain rare, and there are even fewer
aminocatalyzed variants.
Recent years have witnessed a renaissance
in α-functionalizations
of aldehydes, specifically in the context of oxidative umpolung strategies.
Unlike previous open-shell approaches, application of a quinone-based
oxidant in conjunction with an aminocatalyst leads to a discrete,
substitutionally labile quinone adduct. These have proven to be valuable
building blocks toward polar reactivityauguring the advent
of new avenues to construct tetrasubstituted tertiary stereocenters
through the application of conventional nucleophiles to form C–C,
C–N, C–O, and C–S bonds through an organocatalyzed
cross-nucleophile coupling (organo-CNC) reaction. The resulting nonepimerizable
stereocenter demonstrates high optical fidelity and provides a significant
advancement in many applications that suffer from racemization, such
as in vivo studies.
This strategy harnesses
a trifunctional aminocatalyst to promote
an unusual SN2 reaction at a highly congested center. The
selection of the quinone oxidant and nucleophile converges to a continuum
of reactivity ranging from enantioselective oxidation to stereoselective
substitution. A remarkable aspect of these developments is the identification
of an asymmetric SN2 dynamic kinetic resolution (SN2-DKR) manifold. These organo-CNC reactions are highly modular
and demonstrate complete stereocontrol from the catalyst with minimal
influence from incoming chiral nucleophiles. Leveraging this facet,
these technologies have been extended to peptidic bioconjugations
bearing bio-orthogonoal linker molecules.
This Account aims
to highlight the progress, from an internal perspective,
toward directing the initial result into established methodologies.
Within this construct, the underlying principles of each reaction
will be disseminated with specific content on inherent challenges
and opportunity. Combined, these will serve as an instructive tool
to stimulate applications in cross-disciplinary interfaces.